Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who ...

Background: Acute myeloid leukemia (AML) is a hematologic tumor with poor prognosis and significant clinical heterogeneity. By integrating transcriptomic data, single-cell RNA sequencing data and ...

CML is characterized by the presence of a unique gene mutation called the Philadelphia chromosome. Unlike acute myeloid leukemia, CML involves more mature cells of myeloid origin. If left untreated, ...

Early detection and innovative therapies are crucial for managing rare blood disorders like VITT, ITP, and hemophilia. Marstacimab's approval offers a new subcutaneous treatment option for ...

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects white blood cells (WBCs). Since these blood cells are part of the immune system, CLL affects the body’s ability to fight germs.

But research published in the journal Science on Thursday demonstrated that the version of bird flu infecting US cows is now just a single mutation away from being able to spread more effectively ...

TUS+VEN+AZA triplet may establish a more effective, mutation agnostic ... efficacy across AML genetic subgroups – including those with adverse mutations in TP53 and RAS genes, and those with ...

The effective targeting of RAS-mutant acute myeloid leukemia (AML) still remains a challenge; RAS mutations are tied to relapse to targeted therapy, such as resistance to FLT3 inhibitors due to the ...

Acute Myeloid Leukemia (AML) at the 66 th ASH annual meeting. The additional data presented include data for 21 patients with a FLT3 mutation (FLT3m) who had received fewer than 3 lines of prior ...